Tuesday - December 23, 2025
Next-Generation Targeted Alpha Therapy using Astatine Shows Promise in Thyroid Cancer Resistant to C
December 04, 2025
RESTON, Virginia, Dec. 4 [Category: Medical] -- The Society of Nuclear Medicine and Molecular Imaging issued the following news release:

* * *

Next-Generation Targeted Alpha Therapy using Astatine Shows Promise in Thyroid Cancer Resistant to C

*

Reston, VA (December 4, 2025) A new targeted alpha therapy is showing promise for patients whose thyroid cancer no longer responds to radioactive iodine, the standard beta-emitting treatment. In a first . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products